DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1DXCM - US2521311074 - Common Stock
52.28 EUR
-6.77 (-11.46%)
We assign a fundamental rating of 7 out of 10 to 1DXCM. 1DXCM was compared to 65 industry peers in the Health Care Equipment & Supplies industry. 1DXCM scores excellent on profitability, but there are some minor concerns on its financial health. 1DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make 1DXCM suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year 1DXCM was profitable.
1DXCM had a positive operating cash flow in the past year.
In the past 5 years 1DXCM has always been profitable.
1DXCM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1DXCM has a Return On Assets of 9.61%. This is amongst the best in the industry. 1DXCM outperforms 86.89% of its industry peers.
1DXCM has a better Return On Equity (26.44%) than 93.44% of its industry peers.
1DXCM has a better Return On Invested Capital (15.72%) than 95.08% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1DXCM is in line with the industry average of 9.71%.
The 3 year average ROIC (11.25%) for 1DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
With an excellent Profit Margin value of 15.96%, 1DXCM belongs to the best of the industry, outperforming 88.52% of the companies in the same industry.
In the last couple of years the Profit Margin of 1DXCM has grown nicely.
With an excellent Operating Margin value of 18.41%, 1DXCM belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
In the last couple of years the Operating Margin of 1DXCM has grown nicely.
1DXCM has a Gross Margin of 60.20%. This is in the better half of the industry: 1DXCM outperforms 60.66% of its industry peers.
1DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
1DXCM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1DXCM has been increased compared to 1 year ago.
Compared to 5 years ago, 1DXCM has more shares outstanding
The debt/assets ratio for 1DXCM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.68 indicates that 1DXCM is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.68, 1DXCM belongs to the best of the industry, outperforming 85.25% of the companies in the same industry.
1DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as 1DXCM would need 2.36 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.36, 1DXCM is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
A Debt/Equity ratio of 0.47 indicates that 1DXCM is not too dependend on debt financing.
The Debt to Equity ratio of 1DXCM (0.47) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 4.68 |
ROIC/WACC2
WACC7.86%
2.3 Liquidity
1DXCM has a Current Ratio of 1.56. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.56, 1DXCM is in line with its industry, outperforming 45.90% of the companies in the same industry.
A Quick Ratio of 1.38 indicates that 1DXCM should not have too much problems paying its short term obligations.
1DXCM's Quick ratio of 1.38 is fine compared to the rest of the industry. 1DXCM outperforms 63.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
1DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
Measured over the past years, 1DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
1DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
1DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
The Earnings Per Share is expected to grow by 22.40% on average over the next years. This is a very strong growth
1DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.43% yearly.
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.4%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.43%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.67, 1DXCM can be considered very expensive at the moment.
1DXCM's Price/Earnings ratio is in line with the industry average.
1DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.59.
The Price/Forward Earnings ratio is 23.99, which indicates a rather expensive current valuation of 1DXCM.
1DXCM's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of 1DXCM to the average of the S&P500 Index (24.03), we can say 1DXCM is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.67 | ||
| Fwd PE | 23.99 |
4.2 Price Multiples
1DXCM's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, 1DXCM is valued a bit cheaper than 72.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.49 | ||
| EV/EBITDA | 20.06 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of 1DXCM may justify a higher PE ratio.
A more expensive valuation may be justified as 1DXCM's earnings are expected to grow with 22.49% in the coming years.
PEG (NY)1.18
PEG (5Y)1.12
EPS Next 2Y24.04%
EPS Next 3Y22.49%
5. Dividend
5.1 Amount
1DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1DXCM (11/3/2025, 7:00:00 PM)
52.28
-6.77 (-11.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap20.50B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85
Price Target88.5 (69.28%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-4.53%
EPS NQ rev (3m)-6.46%
EPS NY rev (1m)0.59%
EPS NY rev (3m)1.85%
Revenue NQ rev (1m)-1.01%
Revenue NQ rev (3m)-2.76%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.67 | ||
| Fwd PE | 23.99 | ||
| P/S | 5.29 | ||
| P/FCF | 22.49 | ||
| P/OCF | 16.49 | ||
| P/B | 8.76 | ||
| P/tB | 9.1 | ||
| EV/EBITDA | 20.06 |
EPS(TTM)1.6
EY3.06%
EPS(NY)2.18
Fwd EY4.17%
FCF(TTM)2.32
FCFY4.45%
OCF(TTM)3.17
OCFY6.06%
SpS9.89
BVpS5.97
TBVpS5.74
PEG (NY)1.18
PEG (5Y)1.12
Graham Number14.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 4.68 |
F-Score5
WACC7.86%
ROIC/WACC2
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.59%
EPS Next 2Y24.04%
EPS Next 3Y22.49%
EPS Next 5Y22.4%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.4%
Revenue Next 2Y14.3%
Revenue Next 3Y13.94%
Revenue Next 5Y13.43%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.12%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / 1DXCM.MI FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to 1DXCM.MI.
What is the valuation status for 1DXCM stock?
ChartMill assigns a valuation rating of 4 / 10 to DEXCOM INC (1DXCM.MI). This can be considered as Fairly Valued.
What is the profitability of 1DXCM stock?
DEXCOM INC (1DXCM.MI) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for 1DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (1DXCM.MI) is 32.67 and the Price/Book (PB) ratio is 8.76.
What is the expected EPS growth for DEXCOM INC (1DXCM.MI) stock?
The Earnings per Share (EPS) of DEXCOM INC (1DXCM.MI) is expected to grow by 27.59% in the next year.